{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T16:16:19Z","timestamp":1788365779991,"version":"build-2803163510"},"reference-count":47,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T00:00:00Z","timestamp":1781308800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ymthe.2026.06.027","type":"journal-article","created":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T23:39:23Z","timestamp":1781566763000},"page":"5273-5283","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Increasing intrinsic protein disorder improves CD8+ immunogenicity for a SARS CoV2 vaccine candidate antigen"],"prefix":"10.1016","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3326-980X","authenticated-orcid":false,"given":"Li","family":"Wan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingxian","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Shuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maura E.","family":"O'Malley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos J.","family":"Camacho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greg M.","family":"Delgoffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8132-858X","authenticated-orcid":false,"given":"Patrick S.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2026.06.027_bib1","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.3390\/v17081035","article-title":"Primary Sequence-Intrinsic Immune Evasion by Viral Proteins Guides CTL-Based Vaccine Strategies","volume":"17","author":"Wan","year":"2025","journal-title":"Viruses"},{"key":"10.1016\/j.ymthe.2026.06.027_bib2","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.biochi.2023.07.010","article-title":"The hide-and-seek game of the oncogenic Epstein-Barr virus-encoded EBNA1 protein with the immune system: An RNA G-quadruplex tale","volume":"214","author":"Dinh","year":"2023","journal-title":"Biochimie"},{"key":"10.1016\/j.ymthe.2026.06.027_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0002947","article-title":"CRPV genomes with synonymous codon optimizations in the CRPV E7 gene show phenotypic differences in growth and altered immunity upon E7 vaccination","volume":"3","author":"Cladel","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2026.06.027_bib4","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.virusres.2007.04.010","article-title":"Codon usage and replicative strategies of hepatitis A virus","volume":"127","author":"Pint\u00f3","year":"2007","journal-title":"Virus. Res."},{"key":"10.1016\/j.ymthe.2026.06.027_bib5","first-page":"213","article-title":"Rare Human Codons and HCMV Translational Regulation","volume":"27","author":"Kanduc","year":"2017","journal-title":"J. Mol. Microbiol. Biotechnol."},{"key":"10.1016\/j.ymthe.2026.06.027_bib6","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1126\/science.1088902","article-title":"Self-inhibition of synthesis and antigen presentation by Epstein-Barr virus-encoded EBNA1","volume":"301","author":"Yin","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2026.06.027_bib7","doi-asserted-by":"crossref","first-page":"8225","DOI":"10.1128\/JVI.00411-07","article-title":"Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen 1 Mimics Epstein-Barr Virus EBNA1 Immune Evasion through Central Repeat Domain Effects on Protein Processing","volume":"81","author":"Kwun","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2026.06.027_bib8","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.4049\/jimmunol.157.5.1823","article-title":"Defective ribosomal products (DRiPs): a major source of antigenic peptides for MHC class I molecules?","volume":"157","author":"Yewdell","year":"1996","journal-title":"J. Immunol."},{"key":"10.1016\/j.ymthe.2026.06.027_bib9","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/35008096","article-title":"Rapid degradation of a large fraction of newly synthesized proteins by proteasomes","volume":"404","author":"Schubert","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.06.027_bib10","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.virol.2011.01.026","article-title":"The central repeat domain 1 of Kaposi's sarcoma-associated herpesvirus (KSHV) latency associated-nuclear antigen 1 (LANA1) prevents cis MHC class I peptide presentation","volume":"412","author":"Kwun","year":"2011","journal-title":"Virology"},{"key":"10.1016\/j.ymthe.2026.06.027_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.108815","article-title":"Most non-canonical proteins uniquely populate the proteome or immunopeptidome","volume":"34","author":"Ruiz Cuevas","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.ymthe.2026.06.027_bib12","doi-asserted-by":"crossref","first-page":"4690","DOI":"10.1172\/JCI88590","article-title":"MHC class I-associated peptides derive from selective regions of the human genome","volume":"126","author":"Pearson","year":"2016","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymthe.2026.06.027_bib13","doi-asserted-by":"crossref","first-page":"8381","DOI":"10.1073\/pnas.140217397","article-title":"Inhibition of proteasomal degradation by the gly-Ala repeat of Epstein-Barr virus is influenced by the length of the repeat and the strength of the degradation signal","volume":"97","author":"Dantuma","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2026.06.027_bib14","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1128\/jvi.70.1.549-558.1996","article-title":"Primary characterization of a herpesvirus agent associated with Kaposi's sarcomae","volume":"70","author":"Moore","year":"1996","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2026.06.027_bib15","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms16043","article-title":"Nucleolin directly mediates Epstein-Barr virus immune evasion through binding to G-quadruplexes of EBNA1 mRNA","volume":"8","author":"Lista","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.06.027_bib16","doi-asserted-by":"crossref","first-page":"e01508-19","DOI":"10.1128\/JVI.01508-19","article-title":"LANA and hnRNP A1 Regulate the Translation of LANA mRNA through G-Quadruplexes","volume":"94","author":"Dabral","year":"2020","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2026.06.027_bib17","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1172\/JCI125364","article-title":"Heterologous prime-boost vaccination protects against EBV antigen-expressing lymphomas","volume":"129","author":"R\u00fchl","year":"2019","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymthe.2026.06.027_bib18","article-title":"Engineered protein destabilization reverses intrinsic immune evasion for candidate vaccine pan-strain KSHV and SARS-CoV-2 antigens","author":"Wan","year":"2024","journal-title":"bioRxiv."},{"key":"10.1016\/j.ymthe.2026.06.027_bib19","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.ado7588","article-title":"Heterotypic immunity from prior SARS-CoV-2 infection but not COVID-19 vaccination associates with lower endemic coronavirus incidence","volume":"16","author":"Bean","year":"2024","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2026.06.027_bib20","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.28246","article-title":"Development and characterization of a new monoclonal antibody against SARS-CoV-2 NSP12 (RdRp)","volume":"95","author":"Meng","year":"2023","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.ymthe.2026.06.027_bib21","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/s41586-020-2368-8","article-title":"Structure of replicating SARS-CoV-2 polymerase","volume":"584","author":"Hillen","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.06.027_bib22","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1084\/jem.20041912","article-title":"Identification of poxvirus CD8+ T cell determinants to enable rational design and characterization of smallpox vaccines","volume":"201","author":"Tscharke","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ymthe.2026.06.027_bib23","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.imlet.2007.05.007","article-title":"Targeting antigen to MHC Class I and Class II antigen presentation pathways for malaria DNA vaccines","volume":"111","author":"Doba\u00f1o","year":"2007","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.ymthe.2026.06.027_bib24","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1016\/j.febslet.2007.06.005","article-title":"PRT6\/At5g02310 encodes an Arabidopsis ubiquitin ligase of the N-end rule pathway with arginine specificity and is not the CER3 locus","volume":"581","author":"Garz\u00f3n","year":"2007","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ymthe.2026.06.027_bib25","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1101\/SQB.1995.060.01.051","article-title":"The N-end rule","volume":"60","author":"Varshavsky","year":"1995","journal-title":"Cold Spring Harb. Symp. Quant. Biol."},{"key":"10.1016\/j.ymthe.2026.06.027_bib26","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/nrm3217","article-title":"The N-end rule pathway: emerging functions and molecular principles of substrate recognition","volume":"12","author":"Sriram","year":"2011","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ymthe.2026.06.027_bib27","doi-asserted-by":"crossref","first-page":"W676","DOI":"10.1093\/nar\/gkl253","article-title":"QGRS Mapper: a web-based server for predicting G-quadruplexes in nucleotide sequences","volume":"34","author":"Kikin","year":"2006","journal-title":"Nucl. Acid Res."},{"key":"10.1016\/j.ymthe.2026.06.027_bib28","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.3390\/v15122438","article-title":"Nucleolin Regulates the Expression of Kaposi\u2019s Sarcoma-Associated Herpesvirus\u2019 Latency-Associated Nuclear Antigen through G-Quadruplexes in the mRNA","volume":"15","author":"Zareie","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.ymthe.2026.06.027_bib29","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.06.027_bib30","doi-asserted-by":"crossref","first-page":"D368","DOI":"10.1093\/nar\/gkad1011","article-title":"AlphaFold Protein Structure Database in 2024: providing structure coverage for over 214 million protein sequences","volume":"52","author":"Varadi","year":"2024","journal-title":"Nucl. Acid Res."},{"key":"10.1016\/j.ymthe.2026.06.027_bib31","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2304302120","article-title":"Systematic identification of conditionally folded intrinsically disordered regions by AlphaFold2","volume":"120","author":"Alderson","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2026.06.027_bib32","doi-asserted-by":"crossref","first-page":"W297","DOI":"10.1093\/nar\/gkab408","article-title":"IUPred3: prediction of protein disorder enhanced with unambiguous experimental annotation and visualization of evolutionary conservation","volume":"49","author":"Erd\u0151s","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymthe.2026.06.027_bib33","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.gpb.2019.01.004","article-title":"SPOT-Disorder2: improved protein intrinsic disorder prediction by ensembled deep learning","volume":"17","author":"Hanson","year":"2019","journal-title":"Genomics Proteomics Bioinformatics"},{"key":"10.1016\/j.ymthe.2026.06.027_bib34","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1093\/bioinformatics\/btu744","article-title":"DISOPRED3: precise disordered region predictions with annotated protein-binding activity","volume":"31","author":"Jones","year":"2015","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ymthe.2026.06.027_bib35","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1084\/jem.20160801","article-title":"PD-L1 on tumor cells is sufficient for immune evasion in immunogenic tumors and inhibits CD8 T cell cytotoxicity","volume":"214","author":"Juneja","year":"2017","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ymthe.2026.06.027_bib36","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0092-8674(94)90169-4","article-title":"T cell receptor antagonist peptides induce positive selection","volume":"76","author":"Hogquist","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2026.06.027_bib37","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2019.1673125","article-title":"Identification of a neo-epitope dominating endogenous CD8 T cell responses to MC-38 colorectal cancer","volume":"9","author":"Hos","year":"2020","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.ymthe.2026.06.027_bib38","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.3390\/v16101625","article-title":"Differences in Susceptibility to SARS-CoV-2 Infection Among Transgenic hACE2-Hamster Founder Lines","volume":"16","author":"Gibson","year":"2024","journal-title":"Viruses"},{"key":"10.1016\/j.ymthe.2026.06.027_bib39","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1016\/j.celrep.2014.07.055","article-title":"Intrinsically disordered segments affect protein half-life in the cell and during evolution","volume":"8","author":"van der Lee","year":"2014","journal-title":"Cell Rep."},{"key":"10.1016\/j.ymthe.2026.06.027_bib40","doi-asserted-by":"crossref","first-page":"2838","DOI":"10.1128\/JVI.01914-06","article-title":"Understanding the failure of CD8+ T-cell vaccination against simian\/human immunodeficiency virus","volume":"81","author":"De Boer","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2026.06.027_bib41","doi-asserted-by":"crossref","first-page":"611","DOI":"10.3389\/fimmu.2016.00611","article-title":"On the Role of CD8(+) T Cells in Determining Recovery Time from Influenza Virus Infection","volume":"7","author":"Cao","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2026.06.027_bib42","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.06.027_bib43","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.virol.2023.02.011","article-title":"Genetic conservation across SARS-CoV-2 non-structural proteins - Insights into possible targets for treatment of future viral outbreaks","volume":"581","author":"Kandwal","year":"2023","journal-title":"Virology"},{"key":"10.1016\/j.ymthe.2026.06.027_bib44","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/s41541-022-00535-4","article-title":"KSHV (HHV8) vaccine: promises and potential pitfalls for a new anti-cancer vaccine","volume":"7","author":"Casper","year":"2022","journal-title":"NPJ Vaccin."},{"key":"10.1016\/j.ymthe.2026.06.027_bib45","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.4081\/oncol.2012.e17","article-title":"Mechanisms of virus immune evasion lead to development from chronic inflammation to cancer formation associated with human papillomavirus infection","volume":"6","author":"Senba","year":"2012","journal-title":"Oncol. Rev."},{"key":"10.1016\/j.ymthe.2026.06.027_bib46","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1172\/JCI68760","article-title":"Multicolor microRNA FISH effectively differentiates tumor types","volume":"123","author":"Renwick","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymthe.2026.06.027_bib47","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ymeth.2003.11.005","article-title":"Lentiviral and MLV based retroviral vectors for ex vivo and in vivo gene transfer","volume":"33","author":"Blesch","year":"2004","journal-title":"Methods"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001626005046?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001626005046?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T15:20:54Z","timestamp":1788362454000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001626005046"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":47,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S1525001626005046"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.06.027","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increasing intrinsic protein disorder improves CD8+ immunogenicity for a SARS CoV2 vaccine candidate antigen","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.06.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}